573 related articles for article (PubMed ID: 25066859)
1. An oncofetal and developmental perspective on testicular germ cell cancer.
Rijlaarsdam MA; Looijenga LH
Semin Cancer Biol; 2014 Dec; 29():59-74. PubMed ID: 25066859
[TBL] [Abstract][Full Text] [Related]
2. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
3. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract][Full Text] [Related]
4. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
5. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
[TBL] [Abstract][Full Text] [Related]
7. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer.
Eini R; Dorssers LC; Looijenga LH
Int J Dev Biol; 2013; 57(2-4):319-32. PubMed ID: 23784843
[TBL] [Abstract][Full Text] [Related]
8. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.
Hoei-Hansen CE; Sehested A; Juhler M; Lau YF; Skakkebaek NE; Laursen H; Rajpert-de Meyts E
J Pathol; 2006 May; 209(1):25-33. PubMed ID: 16456896
[TBL] [Abstract][Full Text] [Related]
9. [Embryonal germ cells and germ cell tumors].
Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
[TBL] [Abstract][Full Text] [Related]
10. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
Spiller CM; Bowles J; Koopman P
Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
[TBL] [Abstract][Full Text] [Related]
12. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract][Full Text] [Related]
13. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
16. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.
Västermark Å; Giwercman YL; Hagströmer O; Rajpert De-Meyts E; Eberhard J; Ståhl O; Cedermark GC; Rastkhani H; Daugaard G; Arver S; Giwercman A
Eur J Cancer; 2011 Feb; 47(3):413-9. PubMed ID: 20880698
[TBL] [Abstract][Full Text] [Related]
18. The stem cell identity of testicular cancer.
Clark AT
Stem Cell Rev; 2007 Jan; 3(1):49-59. PubMed ID: 17873381
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in testicular germ cell tumor research.
van de Geijn GJ; Hersmus R; Looijenga LH
Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
[TBL] [Abstract][Full Text] [Related]
20. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
